Presentation: Paradigm Biopharma - Ignite Investment Summit, Hong Kong, October 2025
Founder and MD, Mr Paul Rennie, provides a brief overview of Paradigm's clinical development of iPPS for OA and Phase 3 Clinical Trial progress.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Paradigm Biopharmaceuticals a question about this update.